肠黏膜屏障在炎症性肠病中作用机制的研究进展(4)

研究进展

698 ISSN 1009-3079 CN 14-1260/R 世界华人消化杂志　　　　　２０１０年３月８日　　　　第１８卷　　　第７期

■同行评价

IkappaB-alpha 本文选题尚可, 有1560-1563

ubiquitination. Science 2000; 289: 一定的新意, 内容全面, 具有一定的7

Lee J, Gonzales-Navajas JM, Raz E. The "polarizing-可读性.

tolerizing" its 8

Immunopatholrelevance mechanism of intestinal epithelium: Cario 2008; 30: 3-9

to colonic homeostasis. Semin receptor E, epithelial 2 Gerken enhances G, ZO-1-associated Podolsky DK. Toll-like intestinal 9

Gastroenterologybarrier integrity via protein kinase Cinflammatory ooney R, Je 2004; 127: 224-238

C. well D. The genetic bas10

428-442

bowel disease. Dig Dis 2009; is 27: of PSchwarzenbacher roell M, Riedfamily: R. l SThe J, FNod-like ritz JH, Rojas AM, 11

OneOgura Y, Bonen DK, Inohara N, Nicolae DL, Chen 2008; 3: e2119

a tale of similarities and differences. receptor (NLR) PLoS FF, R, Kirschner Duerr Ramos RH, R, Achkar Britton H, Moran T, Karaliuskas frameshift BS, Hanauer JP, SB, Brant Nuñez SR, G, Bayless Cho TM, susceptibility mutation 603-606

to Crohn's in disease. NOD2 associated JH. A Nature 2001; with 411: 12

Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick functions intestinal epithelial cells. as BA, an Podolsky antibacterial DK. factor CARD15/NOD2 in human 13

993-1000

Gastroenterology 2003; 124: Rosenstiel P, Fantini M, Bräutigam K, Kühbacher T, Waetzig GH, Seegert D, Schreiber S. TNF-alpha and IFN-gamma (CARD15) gene in human intestinal epithelial cells. regulate the expression of the NOD2 14

GastroenterologyAn G, Wei B, Xia B, McDaniel JM, Ju T, Cummings 2003; 124: 1001-1009

RD, colitis Braun 15

3-derived O-glycans. and colorectal J, Xia L. Increased tumors in susceptibility mice lacking to Van der Sluis M, De Koning BA, De Bruijn AC, J Exp Med 2007; 204: 1417-1429core Velcich A, Meijerink JP, Van Goudoever JB, Büller HA, Dekker J, Van Seuningen I, Renes IB, Einerhand AW. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic 16

protection. Mashimo Gastroenterology 2006; 131: 117-129

Impaired H, lacking defense Wu DC, of Podolsky intestinal DK, mucosa Fishman MC. 17

262-265

intestinal trefoil factor. Science 1996; in mice 274: McVay S, Barnes Shin ME, LD, Keilbaugh Lehrke M, Lefterova SA, Wong MI, TM, Kierstein MA, SL, Cominelli F, Cohn SM, Hecht Shifflett G, Lazar DE, induced Haczku sodium RELMbeta A, Wu reduces GD. Absence injury in of bacterially 18

116: 2914-2923

sulfate model of colitis. J Clin the Investdextran 2006; Chieppa M, Rescigno M, Huang AY, Germain RN. Dynamic the small bowel lumen in response to epithelial cell imaging of dendritic cell extension into 19

TLR engagement. Niess J Exp Med 2006; 203: 2841-2852McCormick BA, Vyas JM, Boes M, Ploegh HL, Fox JH, Brand S, Gu X, Landsman L, Jung S, JG, dendritic Littman 20

bacterial clearance. cell DR, access Reinecker to the HC. intestinal CX3CR1-mediated lumen and Becker D, C, Wirtz S, ScienceBlessing 2005; 307: 254-258

M, Pirhonen J, Strand Neurath Bechthold MF. Constitutive O, Frick J, Galle p40 promoter activation

PR, Autenrieth I, and mediated by dendritic cells. IL-23 production in the terminal ileum 21

693-706

J Clin Invest 2003; 112: Mizoguchi A, Ogawa A, Takedatsu H, Sugimoto K, Shimomura Y, Shirane K, Nagahama K, Nagaishi T, Mizoguchi E, Blumberg RS, Bhan AK. Dependence of myeloid intestinal 605-615

DC-like granuloma cells. J formation Clin Invest on 2007; unique 117: 22

Ramasundara M, Leach ST, Lemberg DA, Day AS. Defensins in and inflammation: the 23

Hepatolinflammatory bowel disease. role J Gastroenterol of defensins Wehkamp 2009; 24: 202-208

Weichenthal J, Salzman NH, Porter E, Nuding S, Schwab Lima H Jr, Fellermann K, Ganz T, Stange EF, Bevins M, Linzmeier M, Petras RE, R, Feathers Shen B, Schaeffeler RW, Chu H, E, CL. Crohn's disease. Reduced Paneth cell alpha-defensins in ileal 24

18129-18134

Proc Natl Acad Sci U S A 2005; 102: Schenk M, Bouchon A, Birrer S, Colonna M, Mueller C. expressed on myeloid cells-1 are underrepresented Macrophages expressing triggering receptor 25

in the human intestine. Wmacrophages: eber B, Saurer L, J ImmunolMuelle 2005; 174: 517-524r C. Intestinintestinal 26

2009; 31: 171-184

immunopathologies. differentiation and al Semin involvement Immunopatholin Takeda Terada N, Förster I, Akira S. Enhanced Th1 activity K, Clausen BE, Kaisho T, Tsujimura T, and devoid development of chronic enterocolitis in mice 27

Immunityof Stat3 in macrophages and neutrophils. Kamada 1999; 10: 39-49

Matsuoka K, Arai K, Nakai T, Hasegawa A, Inoue N, Hisamatsu T, Okamoto S, Sato T, N, Watanabe N, Akagawa KS, Hibi T. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to 28

bacteria. Fort MM, Leach MW, Rennick DM. A role for NK J Immunol 2005; 175: 6900-6908

cells 29

model of colitis. as regulators of Wells JM, Loonen LM, Karczewski JM. The role of J ImmunolCD4+ 1998; 161: 3256-3261

T cells in a transfer innate signaling in the homeostasis of tolerance and immunity in the intestine. 30

300: 41-48

Int J Med Microbiol 2010; Bruey Balpai JM, Bruey-Sedano N, Osterman A, Matsuzawa S, Terskikh AV, Faustin B, R, Xu C, Kress CL, Bailly-Maitre Luciano F, Zhai B, Li D, X, Reed JC. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 31

Cellactivation by interaction Gionchetti 2007; 129: 45-56

with NALP1. Lammers Miglioli KM, P, Rizzello Brigidi F, P, Helwig Vitali B, U, Poggioli Venturi A, onset placebo-controlled with M, Campieri probiotic M. Prophylaxis of pouchitis G, 32

1202-1209

trial. therapy: Gastroenterologya double-blind, 2003; 124: Elson Lorenz CO, Cong Y, McCracken VJ, Dimmitt RA, inflammatory bowel disease reveal innate, adaptive, RG, Weaver CT. Experimental models of and 33

the microbiota. regulatory mechanisms of host dialogue with Boirivant microflora and immunoregulation. M, Amendola Immunol RevA, 2005; 206: 260-276

Butera A. Intestinal 2008; 1 Suppl 1: S47-S49

Mucosal Immunol 　　　　　　　　　　　编辑　　李瑞敏　　电编　　吴鹏朕